Financial statements Bober-Pharm

Balance sheet of Bober-Pharm

Company age:
Age:
10 y. 1 m. 15 d.
Share capital:
Share capital:
60 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BOBER-PHARM

Year
2018
2019
2020
2021
2022
2023
Total assets 2 289 756,39 2 482 910,92 2 923 326,12 3 008 550,66 3 551 801,09 3 820 378,56
A. Fixed assets 215 437,45 180 997,17 224 240,22 186 185,77 135 965,49 85 745,21
B. Current assets 2 074 318,94 2 301 913,75 2 699 085,90 2 822 364,89 3 415 835,60 3 734 633,35
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 289 756,39 2 482 910,92 2 923 326,12 3 008 550,66 3 551 801,09 3 820 378,56
A. Equity 1 760 878,77 1 850 332,67 2 128 596,12 2 482 006,59 2 566 473,92 2 855 409,57
B. Liabilities and provisions for liabilities 528 877,62 632 578,25 794 730,00 526 544,07 985 327,17 964 968,99
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 403 509,56 492 975,89 648 466,20 349 566,79 805 544,75 790 064,41
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.